A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold

Status:
Unknown status

Trial end date:
2015-06-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether Arbidol (Umifenovir) is effective in the treatment and Prophylaxis of Influenza and Common Cold

Phase 4

Pharmstandard